Adiponectin and Circulating Progenitor Cells (CPC) Function

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01272674
Recruitment Status : Completed
First Posted : January 10, 2011
Last Update Posted : June 2, 2015
German Research Foundation
Heartcenter Leipzig GmbH
Information provided by (Responsible Party):
Prof. Dr. med. A. Linke, University of Leipzig

Brief Summary:
Adiponectin and exercise training contribute to the maintenance of a normal vascular tone by influencing vascular NO bioavailability and concentration and function of endothelial progenitor cells. The molecular mechanisms are only partially understood. Therefore, aim of the present study is to elucidate the effects of Adiponectin on endothelial progenitor cell migration and the underlying signaling pathways. Furthermore, the impact of exercise training on adiponectin-mediated endothelial progenitor cell migration will be investigated.

Condition or disease Intervention/treatment Phase
Coronary Artery Disease Other: exercise training Phase 1

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Adiponectin Promotes the Migration of Circulating Progenitor Cells Through p38-mediated Induction of the CXCR4 Receptor
Study Start Date : January 2011
Actual Primary Completion Date : March 2011
Actual Study Completion Date : March 2011

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: exercise training
4 weeks of supervised physical exercise training
Other: exercise training
4 weeks supervised physical exercise training

No Intervention: control
sedentary lifestyle
No Intervention: healthy control

Primary Outcome Measures :
  1. migratory capacity of endothelial progenitor cells towards an SDF-1 gradient [ Time Frame: 4 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • ≤ 75 years of age
  • stable coronary artery disease
  • preserved left ventricular function
  • physical work capacity of ≥ 50
  • successful elective percutaneous coronary intervention at study begin

Exclusion Criteria:

  • diabetes mellitus
  • hypercholesterolemia
  • untreated hypertension
  • smoking
  • myocardial infarction within the last 4 weeks
  • significant stenosis of the left main coronary artery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01272674

University of Leipzig, Heart Center
Leipzig, Germany, 04289
Sponsors and Collaborators
University of Leipzig
German Research Foundation
Heartcenter Leipzig GmbH
Principal Investigator: Axel Linke, MD Heartcenter Leipzig GmbH

Responsible Party: Prof. Dr. med. A. Linke, Co-investigator, University of Leipzig Identifier: NCT01272674     History of Changes
Other Study ID Numbers: adipo2008
First Posted: January 10, 2011    Key Record Dates
Last Update Posted: June 2, 2015
Last Verified: June 2015

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases